Bio – Talk Bio

Boundless Bio Lays Off 33% of Staff Following Stumble of Lead Program

2 weeks ago talkbio0Tagged BBI-355, BBI-825, Bio, Boundless, CHEK1 protein, human, Clinical Trials, Combined Modality Therapy, Inhibitor, layoffs, pipeline restructuring, ribonucleoside-diphosphate reductase activity, Solid Neoplasm

Boundless Bio; layoffs; biotech; clinical trial; BBI-355; BBI-825; RNR inhibitor; CHK1 inhibitor; combination therapy; solid tumors; pipeline restructuring

GSKs newest neuro pact is with ABL Bio, a Sanofi-partnered South Korean biotech

2 months ago talkbio0Tagged Abetalipoproteinemia, Bio, Blood - brain barrier anatomy, Grabody-B, IGF1R gene, Neurodegenerative Disorders, SmithKline Beecham

Abetalipoproteinemia, SmithKline Beecham, Bio, Grabody-B, Neurodegenerative Disorders, Blood – brain barrier anatomy, IGF1R gene

Drugmakers fear Trump tariffs will drive up manufacturing costs, hurt medicine access: BIO survey

2 months ago talkbio0Tagged Bio, EU, Fear (Mental Process), Financial cost, Manufacture, Surveys

Manufacture, EU, Surveys, Financial cost, Fear (Mental Process), Bio

ReSync Bio, Sapio Sciences adopt Nvidia BioNeMo to supercharge AI drug discovery

3 months ago talkbio0Tagged Aortic Valve Insufficiency, Bio, BioNeMo, Drug Discovery, microservices, NVIDIA 's, Sapio, Sapio Sciences

Drug Discovery, Aortic Valve Insufficiency, Sapio, Sapio Sciences, Bio, NVIDIA ‘s, BioNeMo, microservices

National Resilience Lays Off 120 Employees at Former Bluebird Bio Gene Therapy Facility in Durham, North Carolina

5 months ago talkbio0Tagged Bio, biotech industry, CDMO, Contract Development, Durham/, Family Turdidae (organism), gene therapy, layoffs, Manufacturing Organization, National Resilience, North Carolina

National Resilience, Layoffs, Gene Therapy, Bluebird Bio, Durham/ North Carolina, Biotech Industry, CDMO (Contract Development and Manufacturing Organization)